SAVARINO, EDOARDO VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.486
AS - Asia 16.894
EU - Europa 11.552
AF - Africa 5.513
SA - Sud America 4.555
OC - Oceania 513
Continente sconosciuto - Info sul continente non disponibili 224
Totale 68.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.755
SG - Singapore 5.685
BR - Brasile 2.678
HK - Hong Kong 2.369
IT - Italia 2.266
CN - Cina 2.125
VN - Vietnam 1.328
DE - Germania 937
FI - Finlandia 836
PL - Polonia 666
NL - Olanda 575
RU - Federazione Russa 520
GB - Regno Unito 499
FR - Francia 476
AR - Argentina 361
SE - Svezia 323
MX - Messico 322
AT - Austria 311
IN - India 296
TR - Turchia 260
BJ - Benin 252
EC - Ecuador 249
ES - Italia 248
KR - Corea 246
ID - Indonesia 236
ZA - Sudafrica 214
IE - Irlanda 210
JP - Giappone 204
IQ - Iraq 201
UA - Ucraina 196
JO - Giordania 194
EG - Egitto 193
CO - Colombia 186
PE - Perù 185
AE - Emirati Arabi Uniti 181
AO - Angola 180
PH - Filippine 178
RS - Serbia 175
CL - Cile 172
PY - Paraguay 168
CI - Costa d'Avorio 164
MA - Marocco 164
PK - Pakistan 161
AZ - Azerbaigian 160
BE - Belgio 157
DK - Danimarca 157
UY - Uruguay 156
VE - Venezuela 154
LB - Libano 153
LA - Repubblica Popolare Democratica del Laos 151
PA - Panama 151
RO - Romania 151
CH - Svizzera 150
CZ - Repubblica Ceca 150
GR - Grecia 150
IR - Iran 150
KE - Kenya 150
PT - Portogallo 149
UZ - Uzbekistan 149
DZ - Algeria 148
MU - Mauritius 148
SA - Arabia Saudita 148
KG - Kirghizistan 147
AL - Albania 145
MR - Mauritania 144
BB - Barbados 143
MK - Macedonia 143
NI - Nicaragua 143
NO - Norvegia 143
BA - Bosnia-Erzegovina 142
BF - Burkina Faso 142
GT - Guatemala 142
SN - Senegal 142
ME - Montenegro 141
TH - Thailandia 141
EE - Estonia 140
ML - Mali 140
CY - Cipro 139
HN - Honduras 139
MY - Malesia 139
UG - Uganda 137
GF - Guiana Francese 136
KZ - Kazakistan 136
TN - Tunisia 136
CA - Canada 135
CV - Capo Verde 135
IS - Islanda 134
ET - Etiopia 133
GA - Gabon 133
LV - Lettonia 133
GH - Ghana 132
JM - Giamaica 132
LU - Lussemburgo 132
MW - Malawi 132
DO - Repubblica Dominicana 131
NP - Nepal 131
SK - Slovacchia (Repubblica Slovacca) 131
AM - Armenia 130
BW - Botswana 130
BZ - Belize 130
Totale 62.241
Salva come PNG Salva come JPEG
Città #
Fairfield 4.245
Ashburn 3.217
Singapore 2.945
Hong Kong 2.266
Woodbridge 2.097
Houston 1.990
Seattle 1.525
Cambridge 1.454
Wilmington 1.254
Ann Arbor 1.175
Chandler 1.134
Beijing 706
Boardman 676
Santa Clara 599
San Diego 558
Princeton 458
Bytom 443
Ho Chi Minh City 419
Helsinki 404
Munich 389
Medford 373
Los Angeles 364
Des Moines 303
Cotonou 239
Hanoi 237
Chicago 232
Hefei 229
São Paulo 219
Roxbury 217
Dong Ket 205
New York 205
Padova 203
Milan 199
Amman 185
Vienna 171
Rome 161
Jacksonville 160
Nuremberg 157
Dublin 153
Abidjan 152
Buffalo 150
Baku 147
Luanda 145
Dakar 140
Managua 140
Panama City 136
Nouakchott 132
Vientiane 132
Bridgetown 131
Tashkent 131
Montevideo 130
Libreville 129
Kampala 128
Bishkek 125
London 124
Castries 122
Bamako 120
Dushanbe 120
Nairobi 120
Seoul 120
Conakry 119
Praia 119
Accra 116
Phnom Penh 116
Riga 115
Harare 114
Ulan Bator 114
Lappeenranta 111
Lusaka 109
Redondo Beach 108
Podgorica 107
Nanjing 106
Warsaw 106
Yerevan 106
Ouagadougou 105
Cayenne 104
Lima 103
Antananarivo 101
Reykjavik 101
Kingstown 98
Kinshasa 98
Havana 96
Kigali 96
Lilongwe 95
Andorra la Vella 94
Maputo 94
Addis Ababa 90
Dar es Salaam 90
Belgrade 89
Johannesburg 89
Willemstad 89
Tokyo 88
Minsk 87
Tallinn 87
Djibouti 86
Niamey 86
Noumea 85
San José 85
Istanbul 83
Kingston 82
Totale 38.907
Salva come PNG Salva come JPEG
Nome #
Updates to the modern diagnosis of GERD: Lyon consensus 2.0 621
The natural history of gastro-esophageal reflux disease: a comprehensive review 308
Effects of laparoscopic myotomy on the esophageal motility pattern of esophageal achalasia as measured by high-resolution manometry 289
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 269
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 254
The Role of High-Resolution Manometry Before and Following Antireflux Surgery The Padova Consensus 247
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. 237
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis 236
Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study 222
A modification of Nissen fundoplication improves patients’ outcome and may reduce procedure-related failure rate 215
Superior Mesenteric Artery Syndrome: a Prospective Study in a Single Institution 215
The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon 208
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 208
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis 207
Modulation of inflammation in IBD: Alpha7nAChR expression and role of nicotine 202
The Impact of Heller Myotomy on Integrated Relaxation Pressure in Esophageal Achalasia 202
The natural history of achalasia: Evidence of a continuum-"The evolutive pattern theory" 202
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 198
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients 197
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis 197
Modern diagnosis of GERD: the Lyon Consensus 196
A modified Nissen fundoplication: subjective and objective midterm results 196
Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study 195
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 195
Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria 191
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 191
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 187
The Chicago Classification of esophageal motility disorders, v3.0 185
Comment on "Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis" by Marzio Frazzoni et al. [Digestive and Liver Disease 2014;46:596-602] 185
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab 184
Nonerosive reflux disease: Clinical concepts 183
Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis 183
Indications and interpretation of esophageal function testing 181
A safety review of proton pump inhibitors to treat acid-related digestive diseases 179
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach 179
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 178
Factors associated with disability in patients with ulcerative colitis: A cross-sectional study 177
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 177
Effects of omega-loop bypass on esophagogastric junction function 174
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study 174
Arterial congestive gastropathy: A new entity? 173
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders 171
Anti-Tumor Necrosis Factor Antibodies for Prevention of Crohn's Disease Recurrence After Surgery: More Than a Hope 171
Duodenal Histological Findings and Risk of Coeliac Disease in Subjects with Autoimmune Atrophic Gastritis: A Retrospective Evaluation 171
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease 170
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool 170
Normal values of esophageal motility after antireflux surgery; a study using high-resolution manometry 169
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 169
Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. 169
Esophageal biopsies in the management of GERD: Complementary tool for many but not for all 168
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 168
Quality of life after laparoscopic sigmoid resection for uncomplicated diverticular disease 168
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 167
Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients 166
MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors 166
NERD: an umbrella term including heterogeneous subpopulations. 165
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 163
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success. 163
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 163
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility 162
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab 162
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 162
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy 160
Nonerosive reflux disease and functional heartburn are clearly separate entities. 158
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 158
The 2018 ISDE Achalasia guidelines 157
Esophageal mucosal innervation in functional heartburn: Closer to healthy asymptomatic subjects than to non-erosive reflux disease patients 157
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 156
Case report faecal microbiome transplantation as a solution to chronic enteropathies in dogs: A case study of beneficial microbial evolution 156
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 155
Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis 155
Symptom association analysis is important in GERD patients undergoing endoscopic therapy 154
Letter: proton pump inhibitor-responsive oesophageal eosinophilia – more than just gastro-oesophageal reflux disease. Authors' reply 154
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 154
Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis 154
A survey on nutritional knowledge in coeliac disease compared to inflammatory bowel diseases patients and healthy subjects 153
Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease 153
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD 153
Machine Learning and Canine Chronic Enteropathies: A New Approach to Investigate FMT Effects 152
A more in-depth evaluation of impedance-pH could assist in distinguishing reflux-related from reflux-unrelated heartburn 152
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal 152
Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease 151
Achalasia with dense eosinophilic infiltrate responds to steroid therapy. 151
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 151
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 151
Superior Mesenteric Artery Syndrome as Potential Cause of Antireflux Surgery Failure 150
Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: A useful cutoff in clinical practice 150
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 149
Influence of Diet on the Course of Inflammatory Bowel Disease 149
Gastrointestinal: An unusual rectal finding in a patient with ulcerative colitis 149
Measurement of oro-caecal transit time by magnetic resonance imaging. 148
Updates in the field of non-esophageal gastroesophageal reflux disorder 148
Objective evidence of gastro-esophageal reflux disease is rare in patients with autoimmune gastritis 148
Noninfectious interstitial lung disease during infliximab therapy: case report and literature review. 148
Biliary Tree Diagnostics: Advances in Endoscopic Imaging andand Tissue Sampling 147
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 147
Gastric fundal splenosis presenting as a stromal tumor and diagnosed by endoscopic ultrasound-guided SharkCore biopsy 147
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 146
Letter: Biological therapies are effective for prevention of post-operative Crohn's disease recurrence 146
Advancements in the use of manometry and impedance testing for esophageal functional disorders 146
Totale 18.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.125
article - articoli 221.798
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 443.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.874 0 0 0 0 0 302 385 364 567 479 294 483
2021/20226.157 284 611 666 364 607 304 403 589 544 170 478 1.137
2022/20233.013 732 132 91 352 424 407 28 189 335 57 201 65
2023/20242.499 125 245 207 177 173 211 209 167 141 100 374 370
2024/202512.675 53 714 556 330 1.301 338 642 1.065 1.492 687 2.137 3.360
2025/202632.056 2.146 4.582 9.371 10.113 4.509 1.335 0 0 0 0 0 0
Totale 69.454